Analysis of KAP1 expression patterns and human endogenous retrovirus Env proteins in ovarian cancer

다국어 초록 (Multilingual Abstract)

Background Human endogenous retroviruses (HERVs) constitute around 8% of the human genome and have important roles in human health and disease, including cancers. Previous studies showed that HERV envelope (Env) proteins are highly expressed in cancer tissues and co-related with cancer progression. KAP1 has been reported to play a key role in regulating retrotransposons, including HERV-K, through epigenetic silencing. Objective The relationship between KAP-1 and HERV Envs expressions was analyzed only in tumor cell lines and has not yet been studied in cancer tissues. In this study, we analyzed the expression patterns and relationship between KAP1 and HERV Env proteins in ovarian cancer tissues. Method The expression patterns of KAP-1 and HERV Env proteins, including HERV-K and HERV-R, were analyzed in ovarian cancer tissue microarrays that contained 80 surgical specimens, including normal ovary and malignant ovarian cancers. Results The expression of HERV-R Env and KAP1 proteins is signifcantly higher in ovarian cancer compared with normal ovary tissues. However, the expression of HERV-K Env did not change signifcantly in cancer tissues. The expression patterns of HERV-K Env and HERV-R Env signifcantly increased in early stages of cancer and KAP1 expression was higher in certain stage and types of cancers. However, the expression of HERV-K Env, HERV-R Env, and KAP1 did not change in diferent age groups. The correlation between the expression of KAP1 and HERV-Env, including HERV-K and HERV-R, was not signifcantly correlated. Conclusions The results of this study showed that there was no signifcant correlation between the expression of KAP1 and HERV Env proteins in ovarian cancer tissues, unlike studies with cell lines in vitro. These results suggest that the actual expression of HERV Env proteins in ovarian cancer tissues may be regulated through various complex factors as well as KAP1.

참고문헌 (Reference)

1 Messerschmidt DM, "Trim28 is required for epigenetic stability during mouse oocyte to embryo transition" 335 : 1499-1502, 2012

2 Wolf G, "The KRAB zinc finger protein ZFP809 is required to initiate epigenetic silencing of endogenous retroviruses" 29 : 538-554, 2015

3 Wolf D, "TRIM28 mediates primer binding site-targeted silencing of murine leukemia virus in embryonic cells" 131 : 46-57, 2007

4 Qi ZX, "TRIM28 as an independent prognostic marker plays critical roles in glioma progression" 126 : 19-26, 2016

5 Varghese S, "Site-specific gene expression profiles and novel molecular prognostic factors in patients with lower gastrointestinal adenocarcinoma diffusely metastatic to liver or peritoneum" 14 : 3460-3471, 2007

6 Hahn S, "Serological response to human endogenous retrovirus K in melanoma patients correlates with survival probability" 24 : 717-723, 2008

7 Conley AB, "Retroviral promoters in the human genome" 24 : 1563-1567, 2008

8 Oja M, "Methods for estimating human endogenous retrovirus activities from EST databases" 8 (8): S11-, 2007

9 Lin LF, "Loss of ZBRK1 contributes to the increase of KAP1 and promotes KAP1-mediated metastasis and invasion in cervical cancer" 8 : e73033-, 2013

10 Belshaw R, "Long-term reinfection of the human genome by endogenous retroviruses" 101 : 4894-4899, 2004

11 Imbeault M, "KRAB zinc-finger proteins contribute to the evolution of gene regulatory networks" 543 : 550-554, 2017

12 Cheng CT, "KAPtain in charge of multiple missions : emerging roles of KAP1" 5 : 308-320, 2014

13 Tie CH, "KAP1 regulates endogenous retroviruses in adult human cells and contributes to innate immune control" 19 : e45000-, 2018

14 Wang Y, "KAP1 is overexpressed in hepatocellular carcinoma and its clinical significance" 21 : 927-933, 2016

15 Yokoe T, "KAP1 is associated with peritoneal carcinomatosis in gastric cancer" 17 : 821-828, 2010

16 Rowe HM, "KAP1 controls endogenous retroviruses in embryonic stem cells" 463 : 237-240, 2010

17 Turelli P, "Interplay of TRIM28and DNA methylation in controlling human endogenous retroelements" 24 : 1260-1270, 2014

18 Wang-Johanning F, "Immunotherapeutic potential of anti-human endogenous retrovirus-K envelope protein antibodies in targeting breast tumors" 104 : 189-210, 2012

19 Ishida T, "Identification of the HERV-K gag antigen in prostate cancer by SEREX using autologous patient serum and its immunogenicity" 8 : 15-, 2008

20 Wang-Johanning F, "Human endogenous retrovirus type K antibodies and mRNA as serum biomarkers of early-stage breast cancer" 134 : 587-595, 2013

21 Contreras-Galindo R, "Human endogenous retrovirus K(HML-2)elements in the plasma of people with lymphoma and breast cancer" 82 : 9329-9336, 2008

22 Kang YJ, "Human ERV3-1 env protein expression in various human tissues and tumours" 67 : 86-90, 2014

23 Belshaw R, "Genomewide screening reveals high levels of insertional polymorphism in the human endogenous retrovirus family HERV-K(HML2) : implications for present-day activity" 79 : 12507-12514, 2005

24 김희수, "Expression profiles of HERV-K Env protein in normal and cancerous tissues" 한국유전학회 38 (38): 91-107, 2016

25 Zhao J, "Expression of human endogenous retrovirus type K envelope protein is a novel candidate prognostic marker for human breast cancer" 2 : 914-922, 2011

26 Hu M, "Expression of KAP1 in epithelial ovarian cancer and its correlation with drugresistance" 8 : 17308-17320, 2015

27 Kewitz S, "Expression and regulation of the endogenous retrovirus 3 in Hodgkin’s Lymphoma cells" 3 : 179-, 2013

28 Wang YY, "Clinical utility of measuring expression levels of KAP1, TIMP1 and STC2 in peripheral blood of patients with gastric cancer" 11 : 81-, 2013

29 Jacobs FM, "An evolutionary arms race between KRAB zinc-finger genes ZNF91/93 and SVA/L1 retrotransposons" 516 : 242-245, 2014